文献速递小儿眼科与斜弱视青光眼白内障与屈光手术

儿童白内障术后二期人工晶状体植入与青光眼风险

Does secondary intraocular lens implantation increase the risk of glaucoma in aphakic patients who underwent cataract surgery in childhood?
PubMed 文献 · Br J Ophthalmol · 2026-05-11

该回顾性队列研究纳入57只眼(30只儿童眼0-16岁,27只青年眼17-30岁),评估儿童白内障术后二期人工晶状体(IOL)植入后新发青光眼或青光眼进展的风险。结果显示青光眼进展16眼(28%),主要见于已有青光眼者(15/21,71%),无青光眼者仅1/36(3%)(相对风险25.7;95%CI 3.7至181.0;p<0.0001)。结论认为二期IOL植入在有青光眼眼中与显著进展风险相关,但似乎不太可能诱发无青光眼眼的新发青光眼。

要点

  • 有青光眼眼二期IOL植入后青光眼进展风险显著高于无青光眼眼(RR 25.7)。
  • 葡萄膜炎性白内障眼进展率最高(67%),外伤性白内障眼未见进展。
  • 年龄组和IOL位置与青光眼进展无显著关联。

核心结论

  • 二期IOL植入在有青光眼眼中与显著青光眼进展风险相关,但在无青光眼眼中似乎不太可能诱发新发青光眼。

研究设计与样本

  • 回顾性队列研究,纳入Moorfields Eye Hospital(2017-2025)儿童白内障术后行二期IOL植入的57只眼,排除前房IOL或视网膜病变。

主要发现

  • 57只眼(30只儿童眼0-16岁,27只青年眼17-30岁),平均随访28.2个月(SD±26.4)。
  • 青光眼进展16眼(28%),有青光眼眼15/21(71%)进展,无青光眼眼1/36(3%)进展(相对风险25.7;95%CI 3.7至181.0;p<0.0001)。
  • 葡萄膜炎性眼进展最频繁(67%),外伤性白内障眼未见进展(p=0.00012)。
  • 年龄组或IOL位置与青光眼进展无显著关联。

临床怎么用

  • 对有青光眼病史的患儿行二期IOL植入前应仔细选择患者并充分告知,术后需密切监测青光眼进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Secondary intraocular lens (IOL) implantation is reported to increase glaucoma development and progression in paediatric patients. We evaluated the risk of new-onset glaucoma or progression following secondary IOL implantation in children and young adults. METHODS: Retrospective cohort study of secondary IOL implantation following paediatric cataract surgery at Moorfields Eye Hospital (2017-2025). Anterior chamber IOLs or retinal pathology were excluded. Primary outcome was glaucoma progression (worsening optic disc appearance, sustained intraocular pressure (IOP) elevation requiring medical therapy escalation and/or glaucoma surgery). Secondary outcomes included longitudinal IOP trends and best-corrected visual acuity. RESULTS: 57 eyes were included (30 paediatric, 0-16 years; 27 young adult, 17-30 years); mean follow-up 28.2 months (SD±26.4). Aetiology was congenital (49%), uveitic (26%) and traumatic (25%). IOL position was ciliary sulcus (68%), capsular bag (18%) and scleral-fixated (14%). Glaucoma progression occurred in 16 eyes (28%), predominantly in eyes with pre-existing glaucoma (15/21, 71%), vs 1/36 eyes (3%) without pre-existing glaucoma (relative risk 25.7; 95% CI 3.7 to 181.0; p<0.0001). Progression was most frequent in uveitic eyes (67%) and was not observed in traumatic cataract (p=0.00012). No significant association was observed between age group or IOL position and glaucoma progression. CONCLUSIONS: Secondary IOL implantation is associated with a significant risk of glaucoma progression in eyes with pre-existing glaucoma but appears unlikely to induce new-onset glaucoma in eyes without prior disease. These findings highlight the importance of careful patient selection, counselling and close postoperative surveillance in patients with pre-existing glaucoma undergoing secondary IOL implantation.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Barnett V, Ashton C, Barker L, et al. Does secondary intraocular lens implantation increase the risk of glaucoma in aphakic patients who underwent cataract surgery in childhood? Br J Ophthalmol. 2026. PMID: 42114964. doi:10.1136/bjo-2026-329657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。